Rethinking Clinical Trials

AUGUST 30, 2023

There are 4 components to the treat-to-target approach: record disease activity using a composite measure every 3 months; specify disease activity target; adjust medications to target; and document shared decision making. There are new medications now that were not showing up that required regular updates to the dashboard.

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

Rethinking Clinical Trials

DECEMBER 6, 2022

Medication adherence can be a barrier to effectiveness. The focus of the study was on physical activity and medication adherence. Secondary endpoints were change in medication adherence, change in HRQOL, change in NT-proBNP, and change in hemoglobin A1C from baseline to 3 months. Key Points. One pays more than another.

Trials 130

Trials Clinical Trials Clinical Trials Compliance 130

pharmaphorum

JANUARY 11, 2022

It is well-established for conventional drugs and medical devices but has only recently started to be used for DTx. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on. Last year, Biofourmis said its heart failure tool BiovitalsHF was the first DTx to be awarded breakthrough status by the FDA.

Development 64

Development Production Drugs 64

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Production 264

Production Pharma Production Pharma Companies Drugs 264

XTalks

OCTOBER 12, 2022

For ASL MR perfusion, water molecules in arterial blood from a feeder artery are magnetically tagged and tracked until they reach the region of interest. Then, the signal difference in the region of interest between the tagged images and control images can be computed to obtain cerebral blood flow (CBF) values ( Figure 3 ).

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

Delveinsight

JULY 22, 2020

The Internet of Things is the interconnection of available medical devices, software applications and other resources to collect and exchange data to provide a reliable, efficient, and smart healthcare service to the patients. The data collected in the IoT can support medical research. Medical Information Distribution.

Doctors 59

Doctors Doctor Marketing Production 59

pharmaphorum

NOVEMBER 28, 2022

Substra is the software that powered the MELLODDY platform, a collaboration in which Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Janssen, Merck, Novartis, and Servier all agreed to share drug discovery data — but not with each other directly, nor with Owkin. Open source is undoubtedly the future of AI research.”.

Pharma Companies 72

Pharma Companies Life Science Research Development 72